IMAX (NYSE:IMAX - Get Free Report) is projected to announce its Q3 2026 results before the market opens on Thursday, October 22nd. Analysts expect IMAX to announce earnings of $0.83 per share and revenue of $150.15 million for the quarter. Investors are encouraged to explore the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, October 22, 2026 at 8:30 AM ET.
IMAX (NYSE:IMAX - Get Free Report) last issued its earnings results on Thursday, July 23rd. The company reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.13. The company had revenue of $102.84 million during the quarter, compared to the consensus estimate of $96.09 million. IMAX had a return on equity of 15.47% and a net margin of 9.84%. IMAX's quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.26 earnings per share. On average, analysts expect IMAX to post $1.65 EPS for the current fiscal year and $1.78 EPS for the next fiscal year.
IMAX Trading Down 0.0%
NYSE:IMAX opened at $51.66 on Thursday. The stock has a 50 day moving average of $52.42 and a 200-day moving average of $44.06. The firm has a market capitalization of $2.83 billion, a PE ratio of 71.74, a price-to-earnings-growth ratio of 1.49 and a beta of 0.49. IMAX has a 52 week low of $31.24 and a 52 week high of $57.73.
Key Headlines Impacting IMAX
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: Wedbush raised its price target to $60 from $54 and maintained an Outperform rating. The firm expects IMAX to report record third-quarter results, with global IMAX-screen box office estimated at approximately $712 million—well above its previous $401 million forecast. Wedbush said the strong performance suggests additional upside catalysts remain ahead. IMAX box office surge drives Wedbush target hike
- Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating and kept a $65 price target, implying substantial potential upside based on the referenced share price. The bullish target reflects confidence in IMAX’s earnings growth and premium-format demand.
- Positive Sentiment: Upcoming high-profile film releases could support attendance and premium-format revenue. Greta Gerwig’s Narnia trailer debuted in IMAX, while coverage of the upcoming Street Fighter film highlighted reasons audiences may prefer the IMAX experience. Greta Gerwig Debuts Narnia Trailer in IMAX on Tuesday Street Fighter’s Noah Centineo Reveals Surprising Reason Fans Will Want to See Movie in IMAX
- Neutral Sentiment: IMAX’s theater network continues to expand. Houston’s first dine-in IMAX screen is scheduled to open at a Cypress theater in November, modestly increasing the company’s future screen footprint. Houston's first dine-in IMAX screen coming to Cypress theater in November
- Negative Sentiment: IMAX underperformed some broader cinema-stock gains in recent trading, as AMC and Cinemark rallied on industry-specific developments. This relative weakness suggests investors may already have priced in part of IMAX’s strong box-office outlook.
Insider Activity
In other news, VP Robert D. Lister sold 22,500 shares of IMAX stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $51.58, for a total transaction of $1,160,550.00. Following the sale, the vice president owned 182,375 shares of the company's stock, valued at approximately $9,406,902.50. The trade was a 10.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Natasha Fernandes sold 20,000 shares of the business's stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $54.63, for a total value of $1,092,600.00. Following the transaction, the chief financial officer owned 35,596 shares of the company's stock, valued at approximately $1,944,609.48. This represents a 35.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 507,257 shares of company stock worth $26,673,571 over the last ninety days. 20.55% of the stock is owned by company insiders.
Analysts Set New Price Targets
A number of research analysts recently issued reports on IMAX shares. UBS Group set a $65.00 price objective on IMAX in a research report on Wednesday, October 7th. Wedbush upped their price objective on IMAX from $54.00 to $60.00 and gave the stock an "outperform" rating in a research note on Wednesday. Roth Capital increased their target price on IMAX from $50.00 to $60.00 and gave the stock a "buy" rating in a research report on Thursday, September 3rd. Weiss Ratings raised IMAX from a "buy (b-)" rating to a "buy (b)" rating in a research report on Thursday, October 8th. Finally, The Goldman Sachs Group raised their target price on IMAX from $42.00 to $50.00 and gave the company a "neutral" rating in a research note on Friday, September 4th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $56.62.
Get Our Latest Report on IMAX
IMAX Company Profile
(
Get Free Report)
IMAX Corporation NYSE: IMAX is an entertainment technology company that develops and licenses premium-format motion picture systems for cinemas and other venues. Its offerings combine specialized projection and display technology, immersive sound systems, theater design, and large-format screens to provide audiences with an enhanced presentation experience.
The company supports the theatrical release of films through its IMAX DMR (Digital Media Remastering) process, which adapts and optimizes content for IMAX presentations.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IMAX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.
While IMAX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.